The Prefectural Participation Rates of Lung Cancer Screening Had a Negative Correlation with the Lung Cancer Mortality Rates


Journal

Asian Pacific journal of cancer prevention : APJCP
ISSN: 2476-762X
Titre abrégé: Asian Pac J Cancer Prev
Pays: Thailand
ID NLM: 101130625

Informations de publication

Date de publication:
26 Mar 2019
Historique:
entrez: 27 3 2019
pubmed: 27 3 2019
medline: 31 7 2019
Statut: epublish

Résumé

Background: The participation rate is one of the most important indexes in the cancer screening. Historically in Japan, each local government has developed their own equations to calculate the subjects for population-based screening, which were different from each other, and therefore the participation rates of screening were not comparable. Recently, local governments were ordered to use the standardized equation in reporting data, which made it possible to compare the participation rates of cancer screening nationwide for the first time. We therefore investigated the correlation between the prefectural lung cancer mortality and several indicators of lung cancer screening. Methods: The prefectural participation rates of lung, gastric and colonic cancer screening, test positive rates, attendance rates for further examination, lung cancer detection rates and positive predictive values of lung cancer screening were collected from “Cancer Registration and Statistics” of the National Cancer Research Center website. The age-adjusted lung, gastric and colonic cancer mortality rates, smoking rates were also collected. The EZR software program was used for statistical analyses. Results: The participation rates of lung cancer screening had a strong positive correlation with the participation rates of gastric/colonic cancer screening (P<0.001). The prefectural lung cancer mortality rates had a moderate to weak negative correlation with the participation rates of lung cancer screening (P=0.009). A little correlation was noted between other quality assurance indicators of lung cancer screening and lung cancer mortality rates. Conclusion: These results suggested that participating in lung cancer screening might help reduce lung cancer mortality rates in some extent.

Identifiants

pubmed: 30912404
doi: 10.31557/APJCP.2019.20.3.855
pmc: PMC6825770

Types de publication

Journal Article

Langues

eng

Pagination

855-861

Informations de copyright

Creative Commons Attribution License

Références

Asian Pac J Cancer Prev. ;18(6):1485-1491
pubmed: 28669156
Tohoku J Exp Med. 1991 Jan;163(1):59-71
pubmed: 2048120
Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2808-17
pubmed: 18843027
Lung Cancer. 2001 Dec;34(3):325-32
pubmed: 11714529
Cancer. 2001 Aug 1;92(3):588-94
pubmed: 11505403
Lancet. 1987 May 30;1(8544):1247-9
pubmed: 2884378
BMJ Open. 2017 Aug 23;7(8):e016395
pubmed: 28838894
Public Health. 2018 Jan;154:51-58
pubmed: 29197686
Eur J Cancer. 2002 Jul;38(10):1380-7
pubmed: 12091070
Cancer. 1974 Dec;34(6):2018-27
pubmed: 4434331
BMC Cancer. 2017 Dec 28;17(1):897
pubmed: 29282034
Bone Marrow Transplant. 2013 Mar;48(3):452-8
pubmed: 23208313
Asian Pac J Cancer Prev. ;18(8):2151-2156
pubmed: 28843249
Int J Cancer. 1992 Jan 21;50(2):230-7
pubmed: 1730517
JAMA Intern Med. 2015 Sep;175(9):1483-9
pubmed: 26147578
Br J Cancer. 2001 Nov 2;85(9):1326-31
pubmed: 11720469
Eur J Cancer. 2013 Apr;49(6):1374-403
pubmed: 23485231
Lung Cancer. 1999 Aug;25(2):77-85
pubmed: 10470841

Auteurs

Motoyasu Sagawa (M)

Division of Endoscopy, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan. Email: sagawam@tohoku-mpu.ac.jp

Ryoko Machii (R)

Division of Medical Support and Partnership, Center for Cancer Control and Information Service, National Cancer Center, Tokyo, japan.

Tomio Nakayama (T)

Division of Screening Assessment and Management, Center for Public Health Service, National Cancer Center, Tokyo, Japan.

Takafumi Sugawara (T)

Division of Chest Surgery, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.

Naoya Ishibashi (N)

Division of Chest Surgery, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.

Hideki Mitomo (H)

Division of Chest Surgery, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.

Takashi Kondo (T)

Division of Chest Surgery, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.

Toshiharu Tabata (T)

Division of Chest Surgery, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH